Arginine decreases peroxisome proliferator-activated receptor-γ activity via c-Jun

Molecular and Cellular Biochemistry

Volumn 362, Issue 1-2, 2012, Pages 7-13

  Ban, Kechen ^a   Peng, Zhanglong ^a   Lin, Wei ^a   Kozar, Rosemary A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Arginine; C Jun; Peroxisome proliferatoractivated receptor

Indexed keywords

ARGININE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN C JUN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; IN VITRO STUDY; NONHUMAN; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SMALL INTESTINE MUCOSA; TRANSCRIPTION TERMINATION; ANIMAL EXPERIMENT; INTESTINE EPITHELIUM CELL; MALE; PROTEIN PHOSPHORYLATION;

RATTUS;

ANIMALS; ARGININE; BINDING SITES; CELL LINE; EPITHELIAL CELLS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR GAMMA; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84857059541     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1122-9     Document Type: Article

References (43)

1. Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE (2004) Sepsis: An arginine deficiency state? Crit Care Med 32:2135-2145 (Pubitemid 39372550)
2. Castillo L, Chapman TE, Sanchez M, Yu YM, Burke JF, Ajami AM, Vogt J, Young VR (1993) Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci USA 90:7749-7753 (Pubitemid 23250028)
3. Wu G, Meininger CJ, Knabe DA, Bazer FW, Rhoads JM (2000) Arginine nutrition in development, health and disease. Curr Opin Clin Nutr Metab Care 3:59-66 (Pubitemid 30469106)
4. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153-168
5. Suchner U, Heyland DK, Peter K (2002) Immune-modulatory actions of arginine in the critically ill. Br J Nutr 87(Suppl 1):S121-S132 (Pubitemid 34134112)
6. Wang WW, Qiao SY, Li DF (2009) Amino acids and gut function. Amino Acids 37:105-110
7. Drover JW, Dhaliwal R, Weitzel L, Wischmeyer PE, Ochoa JB, Heyland DK (2011) Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg 212:385-399
8. Zhu X, Herrera G, Ochoa JB (2010) Immunosupression and infection after major surgery: a nutritional deficiency. Crit Care Clin 26:491-500
9. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB (2006) CD11b+Gr-1+myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 176:2085-2094 (Pubitemid 43201655)
10. Kalil AC, Danner RL (2006) L-Arginine supplementation in sepsis: Beneficial or harmful? Curr Opin Crit Care 12:303-308 (Pubitemid 44078141)
11. Bertolini G, Iapichino G, Radrizzani D, Facchini R, Simini B, Bruzzone P, Zanforlin G, Tognoni G (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29:834-840 (Pubitemid 36609578)
12. Sato N, Moore FA, Kone BC, Zou L, Smith MA, Childs MA, Moore-Olufemi S, Schultz SG, Kozar RA (2006) Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol 290:G616-G623
13. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409-435 (Pubitemid 34177889)
14. Martin H (2009) Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat Res 669:1-7
15. Ricote M, Glass CK (2007) PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771:926-935 (Pubitemid 47198544)
16. Ye J (2008) Regulation of PPARgamma function by TNF-alpha. Biochem Biophys Res Commun 374:405-408
17. Burns KA, Vanden Heuvel JP (2007) Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771:952-960 (Pubitemid 47198547)
18. Rotman N, Wahli W (2010) PPAR modulation of kinase-linked receptor signaling in physiology and disease. Physiology (Bethesda) 25:176-185
19. Sato N, Moore FA, Smith MA, Zou L, Moore-Olufemi S, Schultz SG, Kozar RA (2005) Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma 58:455-461 (Pubitemid 40365802)
20. Wagner EF (2010) Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis 69(Suppl 1): i86-i88
21. Shaulian E (2010) AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal 22:894-899
22. Saadeddin A, Babaei-Jadidi R, Spencer-Dene B, Nateri AS (2009) The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol Cancer Res 7:1189-1196
23. Ban K, Santora R, Kozar RA (2011) Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut. Mol Cell Biochem 347:191-199
24. Rapanelli M, Lew SE, Frick LR, Zanutto BS (2010) Plasticity in the rat prefrontal cortex: linking gene expression and an operant learning with a computational theory. PLoS One 5:e8656
25. Kim JB, Wright HM, Wright M, Spiegelman BM (1998) ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 95:4333-4337 (Pubitemid 28207912)
26. Ban K, Kozar RA (2010) Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 299:G1344-G1353
27. Boyle JG, Logan PJ, Ewart MA, Reihill JA, Ritchie SA, Connell JM, Cleland SJ, Salt IP (2008) Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J Biol Chem 283:11210-11217
28. Noda Y, Yamada K, Furukawa H, Nabeshima T (1995) Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur J Pharmacol 286:291-297
29. McVeigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B (2001) Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond) 100:293-387
30. Abdelrahman M, Collin M, Thiemermann C (2004) The peroxisome proliferator-activated receptor-c ligand 15-deoxy-D12, 14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock 22:555-561 (Pubitemid 39576584)
31. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG (2002) Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640-6650 (Pubitemid 34547354)
32. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F (2008) Structure of the intact PPAR-gamma- RXR-alpha nuclear receptor complex on DNA. Nature 456:350-356
33. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK (1997) Transcriptional activation by peroxisome proliferatoractivated receptor gamma is inhibited by phosphorylation at a consensus mitogen- activated protein kinase site. J Biol Chem 272:5128-5132 (Pubitemid 27090069)
34. Liu Y, Huang J, Hou Y, Zhu H, Zhao S, Ding B, Yin Y, Yi G, Shi J, Fan W (2008) Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr 100:552-560
35. Zingarelli B, Cook JA (2005) Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation. Shock 23:393-399 (Pubitemid 40571660)
36. Kaplan JM, Denenberg A, Monaco M, Nowell M, Wong H, Zingarelli B (2010) Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock. Intensive Care Med 36:123-130
37. Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100-2103 (Pubitemid 27020707)
38. Camp HS, Tafuri SR, Leff T (1999) c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptorgamma1 and negatively regulates its transcriptional activity. Endocrinology 140:392-397 (Pubitemid 29011184)
39. Ban K, Sprunt JM, Martin S, Yang P, Kozar RA (2011) Glutamine activates peroxisome proliferator-activated receptor gamma in intestinal epithelial cells via 15-s-hete and 13-OXO-ODE: a novel mechanism. Am J Physiol Gastrointest Liver Physiol (Epub ahead of print)
40. Gelman L, Zhou G, Fajas L, Raspé E, Fruchart JC, Auwerx J (1999) p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J Biol Chem 274:7681-7688
41. Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11:2509-2514 (Pubitemid 26023818)
42. Sano Y, Tokitou F, Dai P, Maekawa T, Yamamoto T, Ishii S (1998) CBP alleviates the intramolecular inhibition of ATF-2 function. J Biol Chem 273:29098-29105 (Pubitemid 28507607)
43. Fu M, Zhang J, Lin Y, Zhu X, Zhao L, Ahmad M, Ehrengruber MU, Chen YE (2003) Early stimulation and late inhibition of peroxisome proliferator- activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads. Biochem J 370(Pt 3):1019-1025 (Pubitemid 36399096)